Stock data

佑全 (6929)

佑全 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$266.44M, up 5.2% from a year earlier. EPS over the last four quarters totals -NT$1.74.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 佑全 in Insightr